Search Results

You are looking at 161 - 170 of 384 items for :

  • "early detection" x
  • Refine by Access: All x
Clear All
Full access


-sensitive, culturally appropriate guidelines for breast cancer early detection, diagnosis, and treatment in low- and middle-income countries. As private sector advisor on the US delegation to the 58th World Health Assembly in Geneva, Switzerland, Dr. Anderson

Full access


. Accessed February 15, 2024. Available at : 3. American Cancer Society . Neuroblastoma early detection, diagnosis, and staging . Accessed February 15, 2024. Available at: https

Full access

Delays in Diagnosis and Treatment of Breast Cancer: A Safety-Net Population Profile

Kshama Jaiswal, Madelyne Hull, Anna L. Furniss, Reina Doyle, Natalia Gayou, and Elizabeth Bayliss

reconstruction . JAMA Facial Plast Surg 2014 ; 16 : 55 – 57 . 21. Miller JW Hanson V Johnson GD . From cancer screening to treatment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program . Cancer 2014

Full access

Diagnostic Delays Are Common Among Patients With Hepatocellular Carcinoma

Nishant Patel, Adam C. Yopp, and Amit G. Singal

: 1264 – 1273 e1 . 2. Bruix J Sherman M . Management of hepatocellular carcinoma: an update . Hepatology 2010 ; 53 : 1 – 35 . 3. Singal AG Pillai A Tiro J . Early detection, curative treatment, and survival rates for

Full access

Advocating for Equity in Cancer Care

James McCanney, Terrell Johnson, Lindsey A.M. Bandini, Shonta Chambers, Lynette Bonar, and Robert W. Carlson

cancer risk factors, reduced likelihood of early detection, and lack of access to high-quality healthcare for timely and effective treatment. 1 To explore these issues, NCCN hosted the 2018 Patient Advocacy Summit: Advocating for Equity in Cancer Care

Full access

Lung Cancer Screening

Douglas E. Wood, George A. Eapen, David S. Ettinger, Lifang Hou, David Jackman, Ella Kazerooni, Donald Klippenstein, Rudy P. Lackner, Lorriana Leard, Ann N. C. Leung, Pierre P. Massion, Bryan F. Meyers, Reginald F. Munden, Gregory A. Otterson, Kimberly Peairs, Sudhakar Pipavath, Christie Pratt-Pozo, Chakravarthy Reddy, Mary E. Reid, Arnold J. Rotter, Matthew B. Schabath, Lecia V. Sequist, Betty C. Tong, William D. Travis, Michael Unger, and Stephen C. Yang

, weight loss); unfortunately, patients with these symptoms usually have advanced lung cancer. Early detection of lung cancer is an important opportunity for decreasing mortality. Considerable interest has been shown in developing screening tools to

Full access

Prostate Cancer, Version 1.2016

James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony Victor D'Amico, Brian J. Davis, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael Hurwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Joshua J. Meeks, David F. Penson, Elizabeth R. Plimack, Julio M. Pow-Sang, David Raben, Sylvia Richey, Mack Roach III, Stan Rosenfeld, Edward Schaeffer, Ted A. Skolarus, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Seth A. Strope, Jonathan Tward, Dorothy A. Shead, and Deborah A. Freedman-Cass

estimate that prostate cancer accounted for 27,540 deaths in 2015. 1 The decreasing and comparatively low death rate suggests that increased public awareness with earlier detection and treatment has affected mortality from this prevalent cancer. The

Full access

The Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN Content

Deborah A. Freedman-Cass, Tanya Fischer, Ash B. Alpert, Juno Obedin-Maliver, Pamela L. Kunz, Wui-Jin Koh, and Robert W. Carlson

this population can span prevention, screening/early detection, treatment, survivorship, and end-of-life care. 41 – 47 Gendered language may render invisible the bodies and experiences of transgender and intersex people and thus leave oncologists

Full access

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020

Featured Updates to the NCCN Guidelines

Dawn Provenzale, Reid M. Ness, Xavier Llor, Jennifer M. Weiss, Benjamin Abbadessa, Gregory Cooper, Dayna S. Early, Mark Friedman, Francis M. Giardiello, Kathryn Glaser, Suryakanth Gurudu, Amy L. Halverson, Rachel Issaka, Rishi Jain, Priyanka Kanth, Trilokesh Kidambi, Audrey J. Lazenby, Lillias Maguire, Arnold J. Markowitz, Folasade P. May, Robert J. Mayer, Shivan Mehta, Swati Patel, Shajan Peter, Peter P. Stanich, Jonathan Terdiman, Jennifer Keller, Mary A. Dwyer, and Ndiya Ogba

one hand, the panel recognizes that for CRC, timely screening and early detection have significant impact on outcomes. In addition, there are multiple, affordable CRC screening options. However, the panel considered several issues in determining

Full access

Databases as Vehicles for Comparative Effectiveness Research

Christina A. Minami and Karl Y. Bilimoria

focused on the question of whether ethnic differences could be attributed to early detection or intrinsic biologic differences. They found that black women in all age groups were more likely to be diagnosed at a later stage than non-Hispanic white women